Contact Us
Progesterone Global Market Report 2025
Global Progesterone Market Report 2025
Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Progesterone Global Market Report 2025

By Product Type (Natural Progesterone, Synthetic Progesterone), By Drug Type (Branded, Generic), By Route Of Administration (Injectable, Oral, Transdermal, Other Routes Of Administration), By Application (Menopause, Contraception, Dysfunctional Uterine Bleeding, Hyperplastic Precursor Lesions, Endometrial Cancer, Other Applications), By End-User (Hospitals, Clinics, Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Progesterone Market?

Progesterone is a steroid hormone primarily involved in the menstrual cycle, pregnancy, and embryogenesis in humans and other species. It prepares the endometrium (lining of the uterus) for the potential implantation of a fertilized egg, maintains early pregnancy, and inhibits further ovulation during pregnancy. Progesterone is also used in hormone replacement therapy and birth control pills (in synthetic forms called progestins).

The main product types of progesterone are natural progesterone and synthetic progesterone. Natural progesterone, often referred to as bioidentical progesterone, is a hormone derived from plants such as soybeans or wild yams. These are available in both branded and generic forms and can be administered via various routes, including injectable, oral, transdermal, and others. It is used for multiple applications such as menopause management, contraception, dysfunctional uterine bleeding, hyperplastic precursor lesions, endometrial cancer, and more. The primary end-users include hospitals, clinics, research institutes, and other healthcare facilities.

Progesterone Market Size and growth rate 2025 to 2029: Graph

What Is The Progesterone Market Size 2025 And Growth Rate?

The progesterone market size has grown rapidly in recent years. It will grow from $1.56 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to rising infertility rates, increasing use in assisted reproductive technology, growing prevalence of menstrual disorders, increasing awareness of women’s health and rising demand for bioidentical hormones.

What Is The Progesterone Market Growth Forecast?

The progesterone market size is expected to see rapid growth in the next few years. It will grow to $3.09 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to growing aging female population, increasing prevalence of hormonal imbalances, rising adoption of transdermal and injectable delivery methods, growing focus on preventive healthcare and increasing healthcare spending. Major trends in the forecast period include advancements in transdermal delivery systems, development of sustained-release formulations, innovations in bioidentical hormone compounding, improved oral bioavailability technologies and smart drug delivery patches.

Customer representative image Book your 30 minutes free consultation with our research experts

How Is The Progesterone Market Segmented?

The progesterone market covered in this report is segmented –

1) By Product Type: Natural Progesterone, Synthetic Progesterone

2) By Drug Type: Branded, Generic

3) By Route Of Administration: Injectable, Oral, Transdermal, Other Routes Of Administration

4) By Application: Menopause, Contraception, Dysfunctional Uterine Bleeding, Hyperplastic Precursor Lesions, Endometrial Cancer, Other Applications

5) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Natural Progesterone: Oral Capsules, Vaginal Gels, Creams, Injections, Suppositories

2) By Synthetic Progesterone: Progestins, Oral Contraceptives, Hormone Replacement Therapy (HRT) Formulations, Injectable Contraceptives, intrauterine devices

What Is Driving The Progesterone Market? Rising Incidence Of Hormonal Disorders Fueling The Growth Of The Market Due To Increasing Demand For Hormonal Balance Therapies

The increasing prevalence of hormonal disorders is expected to propel the growth of the progesterone market going forward. Hormonal disorders refer to medical conditions caused by imbalances or dysfunctions in the body’s endocrine system, which produces and regulates hormones that control vital functions such as metabolism, growth, reproduction, and mood. The increasing prevalence of hormonal disorders is due to modern lifestyle factors, including poor diet, chronic stress, lack of physical activity, and exposure to environmental toxins. Progesterone helps in the management of hormonal disorders by restoring hormonal balance, regulating menstrual cycles, and reducing symptoms linked to estrogen dominance. It also supports the function of other hormones, such as estrogen and cortisol, helping to stabilize overall endocrine system activity and alleviate conditions such as polycystic ovary syndrome (PCOS) and premenstrual syndrome (PMS). For instance, in January 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, polycystic ovary syndrome is a significant public health issue and one of the most common hormonal disorders in women of reproductive age, affecting an estimated 6–13% yearly. Therefore, the increasing prevalence of hormonal disorders drives the growth of the progesterone market.

Who Are The Major Players In The Global Progesterone Market?

Major companies operating in the progesterone market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., Allergan plc, AbbVie Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd, Gedeon Richter Plc., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Cadila Pharmaceuticals Ltd., Aspen Pharmacare, BIOCON Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Beximco Pharmaceuticals Ltd., Besins healthcare (UK) limited., Sichuan Deebio Pharmaceutical Co. Ltd., Changzhou Siyao Pharmaceuticals Co. Ltd., Shanghai Shyndec Pharmaceutical Co. Ltd.

What Are The Key Trends Of The Global Progesterone Market? Advancements In Progesterone Delivery With Soft Vaginal Capsules

Major companies operating in the progesterone market are focusing on developing innovative formulations, such as soft vaginal capsules, to improve patient compliance and enhance drug absorption. Soft vaginal capsules are smooth, gel-like inserts designed for vaginal use that help deliver medication directly to the vaginal area for treating infections, supporting hormonal balance, or maintaining overall vaginal health. For instance, in April 2024, Besins Healthcare (UK) Limited, a UK-based pharmaceutical manufacturing company, launched Prometrium 400mg soft vaginal capsules for preventing miscarriage in women with early pregnancy bleeding and a history of recurrent miscarriage. This innovative formulation is the first licensed product in the UK and is designed to improve patient compliance and therapeutic outcomes by offering a targeted, non-invasive delivery method that enhances progesterone absorption at the site of action.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Progesterone Market? Audax Private Equity Acquires Avantor’s Clinical Services Business To Launch Resonant Clinical Solutions

In October 2024, Audax Private Equity, a US-based private equity firm, acquired the clinical services business of Avantor, Inc. for an undisclosed amount. With this acquisition, Audax aims to establish the business, now rebranded as Resonant Clinical Solutions, as an independent platform in the outsourced clinical trial services sector, enhancing its service offerings and leveraging its long-standing customer relationships. Avantor, Inc. is a US-based biotechnology company that specializes in providing progesterone.

What Is The Regional Outlook For The Global Progesterone Market?

North America was the largest region in the progesterone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the progesterone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the progesterone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Progesterone Market?

The progesterone market consists of sales of oral capsules, vaginal gels, creams, injections, and intrauterine devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Progesterone Industry?

The progesterone market research report is one of a series of new reports from The Business Research Company that provides progesterone market statistics, including progesterone industry global market size, regional shares, competitors with an progesterone market share, detailed progesterone market segments, market trends and opportunities, and any further data you may need to thrive in the progesterone industry. The progesterone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Author : Abhilash Pyata

Progesterone Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.79 billion
Revenue Forecast In 2034 $3.09 billion
Growth Rate CAGR of 14.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The progesterone market covered in this report is segmented –
1) By Product Type: Natural Progesterone, Synthetic Progesterone
2) By Drug Type: Branded, Generic
3) By Route Of Administration: Injectable, Oral, Transdermal, Other Routes Of Administration
4) By Application: Menopause, Contraception, Dysfunctional Uterine Bleeding, Hyperplastic Precursor Lesions, Endometrial Cancer, Other Applications
5) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users Subsegments:
1) By Natural Progesterone: Oral Capsules, Vaginal Gels, Creams, Injections, Suppositories
2) By Synthetic Progesterone: Progestins, Oral Contraceptives, Hormone Replacement Therapy (HRT) Formulations, Injectable Contraceptives, Intrauterine Devices
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Merck & Co Inc., Allergan plc, AbbVie Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd, Gedeon Richter Plc., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Cadila Pharmaceuticals Ltd., Aspen Pharmacare, BIOCON Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Beximco Pharmaceuticals Ltd., Besins healthcare (UK) limited., Sichuan Deebio Pharmaceutical Co. Ltd., Changzhou Siyao Pharmaceuticals Co. Ltd., Shanghai Shyndec Pharmaceutical Co. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Progesterone Market Characteristics

3. Progesterone Market Trends And Strategies

4. Progesterone Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Progesterone Growth Analysis And Strategic Analysis Framework

5.1. Global Progesterone PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Progesterone Market Growth Rate Analysis

5.4. Global Progesterone Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Progesterone Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Progesterone Total Addressable Market (TAM)

6. Progesterone Market Segmentation

6.1. Global Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Natural Progesterone

Synthetic Progesterone

6.2. Global Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Branded

Generic

6.3. Global Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable

Oral

Transdermal

Other Routes Of Administration

6.4. Global Progesterone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Menopause

Contraception

Dysfunctional Uterine Bleeding

Hyperplastic Precursor Lesions

Endometrial Cancer

Other Applications

6.5. Global Progesterone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Research Institutes

Other End-Users

6.6. Global Progesterone Market, Sub-Segmentation Of Natural Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral capsules

Vaginal gels

Creams

Injections

Creams

Suppositories

6.7. Global Progesterone Market, Sub-Segmentation Of Synthetic Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Progestins

Oral Contraceptives

Hormone Replacement Therapy (HRT) Formulations

Injectable Contraceptives

Intrauterine Devices

7. Progesterone Market Regional And Country Analysis

7.1. Global Progesterone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Progesterone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Progesterone Market

8.1. Asia-Pacific Progesterone Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Progesterone Market

9.1. China Progesterone Market Overview

9.2. China Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Progesterone Market

10.1. India Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Progesterone Market

11.1. Japan Progesterone Market Overview

11.2. Japan Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Progesterone Market

12.1. Australia Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Progesterone Market

13.1. Indonesia Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Progesterone Market

14.1. South Korea Progesterone Market Overview

14.2. South Korea Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Progesterone Market

15.1. Western Europe Progesterone Market Overview

15.2. Western Europe Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Progesterone Market

16.1. UK Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Progesterone Market

17.1. Germany Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Progesterone Market

18.1. France Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Progesterone Market

19.1. Italy Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Progesterone Market

20.1. Spain Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Progesterone Market

21.1. Eastern Europe Progesterone Market Overview

21.2. Eastern Europe Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Progesterone Market

22.1. Russia Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Progesterone Market

23.1. North America Progesterone Market Overview

23.2. North America Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Progesterone Market

24.1. USA Progesterone Market Overview

24.2. USA Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Progesterone Market

25.1. Canada Progesterone Market Overview

25.2. Canada Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Progesterone Market

26.1. South America Progesterone Market Overview

26.2. South America Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Progesterone Market

27.1. Brazil Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Progesterone Market

28.1. Middle East Progesterone Market Overview

28.2. Middle East Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Progesterone Market

29.1. Africa Progesterone Market Overview

29.2. Africa Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Progesterone Market Competitive Landscape And Company Profiles

30.1. Progesterone Market Competitive Landscape

30.2. Progesterone Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Allergan plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Progesterone Market Other Major And Innovative Companies

31.1. Bayer AG

31.2. Teva Pharmaceutical Industries Ltd.

31.3. Sun Pharmaceutical Industries Ltd

31.4. Gedeon Richter Plc.

31.5. Dr. Reddy’s Laboratories Ltd.

31.6. Cipla Limited

31.7. Cadila Pharmaceuticals Ltd.

31.8. Aspen Pharmacare

31.9. BIOCON Ltd.

31.10. Zhejiang Xianju Pharmaceutical Co. Ltd.

31.11. Beximco Pharmaceuticals Ltd.

31.12. Besins healthcare (UK) limited.

31.13. Sichuan Deebio Pharmaceutical Co. Ltd.

31.14. Changzhou Siyao Pharmaceuticals Co. Ltd.

31.15. Shanghai Shyndec Pharmaceutical Co. Ltd.

32. Global Progesterone Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Progesterone Market

34. Recent Developments In The Progesterone Market

35. Progesterone Market High Potential Countries, Segments and Strategies

35.1 Progesterone Market In 2029 - Countries Offering Most New Opportunities

35.2 Progesterone Market In 2029 - Segments Offering Most New Opportunities

35.3 Progesterone Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Progesterone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Progesterone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Progesterone Market, Sub-Segmentation Of Natural Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Progesterone Market, Sub-Segmentation Of Synthetic Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Progesterone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Progesterone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Pfizer Inc. Financial Performance
  • Table 79: Johnson & Johnson Financial Performance
  • Table 80: Merck & Co Inc. Financial Performance
  • Table 81: Allergan plc Financial Performance
  • Table 82: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Progesterone Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Progesterone Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Progesterone Market, Sub-Segmentation Of Natural Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Progesterone Market, Sub-Segmentation Of Synthetic Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Progesterone Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Progesterone Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Progesterone Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Progesterone Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Progesterone Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Pfizer Inc. Financial Performance
  • Figure 79: Johnson & Johnson Financial Performance
  • Figure 80: Merck & Co Inc. Financial Performance
  • Figure 81: Allergan plc Financial Performance
  • Figure 82: AbbVie Inc. Financial Performance

Frequently Asked Questions

Progesterone is a steroid hormone primarily involved in the menstrual cycle, pregnancy, and embryogenesis in humans and other species. It prepares the endometrium (lining of the uterus) for the potential implantation of a fertilized egg, maintains early pregnancy, and inhibits further ovulation during pregnancy. Progesterone is also used in hormone replacement therapy and birth control pills (in synthetic forms called progestins). For further insights on the Progesterone market, request a sample here

The Progesterone market major growth driver - Rising Incidence Of Hormonal Disorders Fueling The Growth Of The Market Due To Increasing Demand For Hormonal Balance Therapies. For further insights on the Progesterone market, request a sample here

The Progesterone market size has grown strongly in recent years. The progesterone market size has grown rapidly in recent years. It will grow from $1.56 billion in 2024 to $1.79 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to rising infertility rates, increasing use in assisted reproductive technology, growing prevalence of menstrual disorders, increasing awareness of women’s health and rising demand for bioidentical hormones. The progesterone market size is expected to see rapid growth in the next few years. It will grow to $3.09 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to growing aging female population, increasing prevalence of hormonal imbalances, rising adoption of transdermal and injectable delivery methods, growing focus on preventive healthcare and increasing healthcare spending. Major trends in the forecast period include advancements in transdermal delivery systems, development of sustained-release formulations, innovations in bioidentical hormone compounding, improved oral bioavailability technologies and smart drug delivery patches. For further insights on the Progesterone market, request a sample here

The progesterone market covered in this report is segmented –
1) By Product Type: Natural Progesterone, Synthetic Progesterone
2) By Drug Type: Branded, Generic
3) By Route Of Administration: Injectable, Oral, Transdermal, Other Routes Of Administration
4) By Application: Menopause, Contraception, Dysfunctional Uterine Bleeding, Hyperplastic Precursor Lesions, Endometrial Cancer, Other Applications
5) By End-User: Hospitals, Clinics, Research Institutes, Other End-Users

Subsegments:
1) By Natural Progesterone: Oral Capsules, Vaginal Gels, Creams, Injections, Suppositories
2) By Synthetic Progesterone: Progestins, Oral Contraceptives, Hormone Replacement Therapy (HRT) Formulations, Injectable Contraceptives, Intrauterine Devices For further insights on the Progesterone market,
request a sample here

North America was the largest region in the progesterone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the progesterone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Progesterone market, request a sample here.

Major companies operating in the progesterone market are Pfizer Inc., Johnson & Johnson, Merck & Co Inc., Allergan plc, AbbVie Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd, Gedeon Richter Plc., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Cadila Pharmaceuticals Ltd., Aspen Pharmacare, BIOCON Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Beximco Pharmaceuticals Ltd., Besins healthcare (UK) limited., Sichuan Deebio Pharmaceutical Co. Ltd., Changzhou Siyao Pharmaceuticals Co. Ltd., Shanghai Shyndec Pharmaceutical Co. Ltd. . For further insights on the Progesterone market, request a sample here.

Major trends in the Progesterone market include Advancements In Progesterone Delivery With Soft Vaginal Capsules. For further insights on the Progesterone market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon